These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 7520906
1. Extrapyramidal side effects and tolerability of risperidone: a review. Owens DG. J Clin Psychiatry; 1994 May; 55 Suppl():29-35. PubMed ID: 7520906 [Abstract] [Full Text] [Related]
2. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W. J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702 [Abstract] [Full Text] [Related]
3. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials. Weiden PJ, Cutler AJ, Polymeropoulos MH, Wolfgang CD. J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908 [Abstract] [Full Text] [Related]
4. Adverse effects of risperidone and haloperidol treatment in schizophrenia. Yen YC, Lung FW, Chong MY. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424 [Abstract] [Full Text] [Related]
5. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Keegan D. Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051 [Abstract] [Full Text] [Related]
6. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Fleischhacker WW, Lemmens P, van Baelen B. Pharmacopsychiatry; 2001 May; 34(3):104-10. PubMed ID: 11434401 [Abstract] [Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
12. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol. Kim JH, Byun HJ. J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study. Möller HJ, Pelzer E, Kissling W, Riehl T, Wernicke T. Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925 [Abstract] [Full Text] [Related]
14. Negative symptoms in schizophrenia: assessment of the effect of risperidone. Schooler NR. J Clin Psychiatry; 1994 May; 55 Suppl():22-8. PubMed ID: 7520905 [Abstract] [Full Text] [Related]
15. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol]. López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A. Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 May; 24(4):165-72. PubMed ID: 8984849 [Abstract] [Full Text] [Related]